Medicinal cannabinoids: current regulations for prescribing

Recent amendments have been made to regulations concerning the prescription of some medicinal cannabis products. For primary care, these changes will have minimal impact as there is presently only one approved product available for prescription for use in some patients with multiple sclerosis, and no products that are subsidised.

View article

Managing pain in osteoarthritis: focus on the person

The progression of osteoarthritis varies from person to person. Functional decline and worsening of symptoms is not...

Celecoxib: the “need to know” for safe prescribing

Celecoxib is a selective cyclo-oxygenase-2 (COX-2) inhibitor that has been fully subsidised without restriction, since 1 June, 2017.

Methylnaltrexone is a subsidised treatment option for opioid-induced constipation in palliative care

Methylnaltrexone injections are now subsidised for the treatment of opioid-induced constipation...

Diagnosing and managing headache in adults in primary care

A systematic approach is recommended when assessing patients with headache to rule out serious underlying conditions and to ensure...

The bpacnz COPD prescribing tool has been updated

The bpacnz COPD prescribing tool was developed based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD 2016)...

Intravenous ferric carboxymaltose: now available for the treatment of iron deficiency

Intravenous ferric carboxymaltose is now a potential option for treating patients with iron deficiency anaemia in the community.

Feature letters New

Selected letters from readers with interactive feedback

View letters

Antibiotics Guide Updated

Antibiotics Guide 2017 edition

View Guide

The COPD prescribing tool Updated

Pharmacological treatment options for patients with COPD

View Tool

Personalised Prescribing Reports

Access your personalised prescribing reports

View reports

Peer Group Discussions

Discussion points for peer groups or self-reflection of practice

View all discussions


Audits are endorsed by the RNZCGP as a CQI activity for allocation of MOPS credits for General Practitioners

View all audits

CME Quizzes

Quizzes are endorsed by RNZCGP for allocation of MOPS credits

Do Quizzes

Coming up...

the next articles in our “managing pain” theme include osteoarthritis, celecoxib, pregabalin, gabapentin and prescribing cannabis-based products.

Coming soon...

our next theme will be “Trends in primary care”, including gout, early onset type 2 diabetes, immune checkpoint inhibitors and the “triple whammy”.

Made with by the bpacnz team